Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report

Peer Review reports

Original Submission
22 Aug 2019	Submitted	Original manuscript
18 Jun 2020	Reviewed	Reviewer Report - Jose Mauricio Mota
10 May 2021	Author responded	Author comments - Yasuyuki Miyauchi
Resubmission - Version 2
10 May 2021	Submitted	Manuscript version 2
27 Jun 2021	Reviewed	Reviewer Report - Krishna Irrinki
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
6 Sep 2021	Editorially accepted
15 Oct 2021	Article published	10.1186/s13256-021-03097-6

Back to article page